They demonstrated that infusions of nanoparticles formulated with mRNAs encoding interferon regulatory factor 5, in combination with its activating kinase IKKβ ≤, reverse the immunosuppressive, tumor-supporting state of GAMs and reprogram them to a phenotype that induces anti-tumor immunity and promotes tumor regression [87]. This evidence concerns the gene IRF5 and neoplasm.